Characterization of immune responses caused by bovine leukemia virus envelope peptides in sheep.
暂无分享,去创建一个
[1] G. Splitter,et al. Interleukin-12 p40 mRNA Expression in Bovine Leukemia Virus-Infected Animals: Increase in Alymphocytosis but Decrease in Persistent Lymphocytosis , 1998, Journal of Virology.
[2] W. Davis,et al. B-Lymphocyte Proliferation during Bovine Leukemia VirusInduced Persistent Lymphocytosis Is Enhanced by T-Lymphocyte-Derived Interleukin-2 , 1998, Journal of Virology.
[3] P. V. van Rijn,et al. Glycoprotein Erns of pestiviruses induces apoptosis in lymphocytes of several species , 1997, Journal of virology.
[4] G. Splitter,et al. Increased interleukin-10 mRNA expression in tumor-bearing or persistently lymphocytotic animals infected with bovine leukemia virus , 1996, Journal of virology.
[5] M. Onuma,et al. Induction of bovine leukaemia virus Env-specific Th-1 type immunity in mice by vaccination with short synthesized peptide-liposome. , 1996, Vaccine.
[6] K. Ohashi,et al. An effective peptide vaccine to eliminate bovine leukaemia virus (BLV) infected cells in carrier sheep. , 1996, Vaccine.
[7] R. Kettmann,et al. Cellular pathways involved in the ex vivo expression of bovine leukemia virus , 1996, Journal of virology.
[8] N. Day,et al. Immunosuppressive retroviral peptides: cAMP and cytokine patterns. , 1995, Immunology today.
[9] W. Davis,et al. Up-regulation of IL-2 receptor alpha and MHC class II expression on lymphocyte subpopulations from bovine leukemia virus infected lymphocytotic cows. , 1995, Veterinary immunology and immunopathology.
[10] N. Day,et al. Induction of intracellular cAMP by a synthetic retroviral envelope peptide: a possible mechanism of immunopathogenesis in retroviral infections. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[11] N. Day,et al. Differential modulation of Th1- and Th2-related cytokine mRNA expression by a synthetic peptide homologous to a conserved domain within retroviral envelope protein. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[12] F. Annunziato,et al. Th2-like CD8+ T cells showing B cell helper function and reduced cytolytic activity in human immunodeficiency virus type 1 infection , 1994, The Journal of experimental medicine.
[13] A. Burny,et al. Mapping of B-neutralizing and T-helper cell epitopes on the bovine leukemia virus external glycoprotein gp51 , 1993, Journal of virology.
[14] M. Gatei,et al. T-cell responses to highly conserved CD4 and CD8 epitopes on the outer membrane protein of bovine leukemia virus: relevance to vaccine development , 1993, Journal of virology.
[15] X. Jin,et al. Quantitative analysis of the human immunodeficiency virus type 1 (HIV- 1)-specific cytotoxic T lymphocyte (CTL) response at different stages of HIV-1 infection: differential CTL responses to HIV-1 and Epstein- Barr virus in late disease , 1993, The Journal of experimental medicine.
[16] M. Clerici,et al. A TH1-->TH2 switch is a critical step in the etiology of HIV infection. , 1993, Immunology today.
[17] W. A. Jensen,et al. Inhibition of protein kinase C results in decreased expression of bovine leukemia virus , 1992, Journal of virology.
[18] J. Convit,et al. Differing lymphokine profiles of functional subsets of human CD4 and CD8 T cell clones. , 1991, Science.
[19] J. Rovnak,et al. In vivo transcription of the bovine leukemia virus tax/rex region in normal and neoplastic lymphocytes of cattle and sheep , 1991, Journal of virology.
[20] R. Gottlieb,et al. Inhibition of protein kinase C by a peptide conjugate homologous to a domain of the retroviral protein p15E. , 1990, Journal of immunology.
[21] L. Babiuk,et al. Inhibition of antigen-induced and interleukin-2-induced proliferation of bovine peripheral blood leukocytes by inactivated bovine herpes virus 1 , 1990, Journal of virology.
[22] T. Mosmann,et al. Homology of cytokine synthesis inhibitory factor (IL-10) to the Epstein-Barr virus gene BCRFI. , 1990, Science.
[23] I. Chen,et al. Regulation of human T cell leukemia virus expression 1 , 1990, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[24] Inhibition of antigen-induced lymphocyte proliferation by Tat protein from HIV-1. , 1990, Disease markers.
[25] M. Dodon,et al. Direct activation of resting T lymphocytes by human T-lymphotropic virus type I , 1987, Nature.
[26] R. Gallo,et al. Influence of the human T-lymphotropic virus/lymphadenopathy-associated virus on functions of human lymphocytes: evidence for immunosuppressive effects and polyclonal B-cell activation by banded viral preparations. , 1985, Proceedings of the National Academy of Sciences of the United States of America.
[27] E. Esteban,et al. Characterization of the blood lymphocyte population in cattle infected with the bovine leukemia virus. , 1985, Cancer research.
[28] A. Burny,et al. Bovine leukemia virus: an exogenous RNA oncogenic virus. , 1976, Proceedings of the National Academy of Sciences of the United States of America.